Onconova Therapeutics: Funding, Investors & Team (Oct 2026)
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, Onconova has created an extensive library of targeted anti-cancer agents designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. It has three product candidates in clinical trials and six active pre-clinical programs. Onconova seeks to develop products that improve the outcome for cancer patients by directly addressing the disease, its recurrence, and the burden of side-effects associated with current methods of treatment.
Onconova Therapeutics has raised $21.0M across 1 funding round on record, the most recent a Post-IPO Equity of $21.0M announced in Sep 2021.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Onconova Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2021.
Onconova Therapeutics Funding Rounds
Onconova Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Onconova Therapeutics Funding Compared to Other Biotechnology Startups
Onconova Therapeutics' latest round of $21.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Onconova Therapeutics in Biotechnology and Newtown
Companies Similar to Onconova Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Onconova Therapeutics Funding FAQs
What does Onconova Therapeutics do?
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, Onconova has created an extensive library of targeted anti-cancer agents designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. It has three product candidates in clinical trials and six active pre-clinical programs. Onconova seeks to develop products that improve the outcome for cancer patients by directly addressing the disease, its recurrence, and the burden of side-effects associated with current methods of treatment.
How much funding has Onconova Therapeutics raised?
Onconova Therapeutics has raised $21.0M across 1 round on record. The most recent is a Post-IPO Equity of $21.0M announced in Sep 2021.
When did Onconova Therapeutics last raise funding?
Onconova Therapeutics' most recent funding round on record is a Post-IPO Equity of $21.0M, announced in Sep 2021.
Who is the CEO of Onconova Therapeutics?
Steven Fruchtman is listed as CEO at Onconova Therapeutics.
Where is Onconova Therapeutics headquartered?
Onconova Therapeutics is based in Newtown, Pennsylvania, United States.
How many employees does Onconova Therapeutics have?
Onconova Therapeutics is in the 11-50 employee band.
How does Onconova Therapeutics' funding compare to other Biotechnology startups?
Onconova Therapeutics' latest round of $21.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Onconova Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Onconova Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.